Established in 2012, the Kidney Health Initiative is a public-private partnership between the American Society of Nephrology and the US Food and Drug Administration (FDA) whose mission is to catalyze innovation and the development of safe and effective patient-centered therapies for people with kidney diseases.
KHI works closely with the four centers of FDA:
- Center for Devices and Radiological Health (CDRH)
- Center for Drug Evaluation and Research (CDER)
- Center for Biologics Evaluation and Research (CBER)
- Center for Food Safety and Applied Nutrition (CFSAN)
Memorandum of Understanding
… As medicine evolves into the provision of personalized care, so too must care for patients or people living with kidney diseases. KHI, through its multidisciplinary partners, is poised to meet these challenges and ensure the safe introduction of new technologies and therapeutics to enhance the care of patients with kidney diseases.
Mark Okusa, MD, FASN
2018 President of the American Society of Nephrology